Lv6
2080 积分 2023-12-13 加入
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab–Bevacizumab
1个月前
已关闭
Lenvatinib as Second-Line Treatment after Atezolizumab plus Bevacizumab for Unresectable Hepatocellular Carcinoma: Clinical Results Show Importance of Hepatic Reserve Function
1个月前
已完结
Correction to Lancet Oncol 2023; 24: 1399–410
1个月前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
1个月前
已完结
Hepatocellular carcinoma
1个月前
已完结
DCAF12 Ubiquitin Ligase Promotes Lung Cancer Metastasis by Modulating the TRiC/CCT Chaperonin Complex
4个月前
已完结
DCAF12 Ubiquitin Ligase Promotes Lung Cancer Metastasis by Modulating the TRiC/CCT Chaperonin Complex
7个月前
已完结
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
7个月前
已完结
Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency
7个月前
已完结
皖公网安备34019202002308
